Genome-wide analysis of topoisomerase removal after campothecin treatment in the context of replication and transcription
Camptothecin (CPT) and its derivatives (e.g. Irinotecan) are commonly used anticancer drugs which increase the half-life of topoisomerase I (Top1) cleavage complexes (Top1cc) during the Top1 catalytic cycle. Even in the presence of CPT Top1 will eventually remove itself by resuming its catalytic cyc...
Main Author: | Garrido, Karim Ashour |
---|---|
Published: |
Bangor University
2015
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.683527 |
Similar Items
-
Roles of BRCA1 and BRCA2 in DNA replication and genome stability
by: Zimmer, Jutta
Published: (2017) -
Colorectal cancer susceptibility : from candidate gene to genome-wide association
by: Kössler, Thibaud
Published: (2010) -
Genome-wide DNA methylation and gene expression profiling of cancer-associated myofibroblasts
by: Najgebauer, H.
Published: (2016) -
Genome-wide analyses reveal new insights into MLL fusion protein recruitment mechanisms
by: Kerry, Jonathan
Published: (2015) -
Proteins of the vertebrate pre-replication complex
by: Assenberg, Magdalena
Published: (2002)